UK Companies House feature
GLUCO RX LIMITED
Cash
£4M
-1.6% vs 2024
Net assets
£101M
+15.9% vs 2024
Employees
54
+10.2% vs 2024
Profit before tax
—
Period ending 2025-03-31
Profile
- Company number
- 07513682
- Status
- Active
- Incorporation
- 2011-02-02
- Last accounts made up
- 2025-03-31
- Account category
- GROUP
- Primary SIC
- 32500
- Hubs
- UK Healthcare
Cash
7-year trend · vs UK Healthcare median
Accounts
7-year trend · latest 2025-03-31
| Metric | Trend | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | — | — | |
| Profit before tax | — | — | — | — | — | — | — | |
| Net profit | — | — | — | — | — | £12,396,901 | £13,877,364 | |
| Cash | — | — | £29,651,494 | £38,515,036 | £25,706,404 | £3,829,817 | £3,768,662 | |
| Total assets less current liabilities | — | — | £45,445,462 | — | — | £87,551,665 | £101,438,858 | |
| Net assets | — | — | — | — | — | — | — | |
| Equity | £35,559,152 | £30,839,874 | £45,445,462 | £61,531,086 | £75,427,043 | £87,500,995 | £101,378,359 | |
| Average employees | — | — | 63 | — | — | 49 | 54 | |
| Wages | — | — | — | — | — | £2,023,553 | £2,252,331 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated (group)
- Auditor
- Cheesmans
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Subsidiaries
- GlucoRX Technologies Limited · 100% held · Scotland
- Borg Pharma Limited · 100% held
- Pharmacy Link Limited · 100% held
- Microvisk Technologies Limited · 100% held
- Microvisk Limited · 100% held
- Microvisk Technologies International Limited · 100% held
- Conker PJ Limited · 100% held
- Gluco RX Healthcare Private Limited · 100% held · India
- Gluco RX Europe Limited · 100% held · Ireland
Significant events
- “Expansion of Portfolio: Broadening offerings in diabetes and other therapeutic areas, including cardiovascular and pain management.”
- “Globalisation Strategy: Transitioning from a UK-centric model to a global healthcare provider, leveraging success in the UK to penetrate international markets.”
- “R&D Innovation: Investing in ground breaking, non-invasive technologies and multiparameter monitoring systems.”
- “Phase 1: India (Operational): GlucoRx has already commenced operations in India through GlucoRx Healthcare Private Limited, based in Mumbai.”
- “Phase 2: MENA Region (Upcoming): Building on the momentum in India, the company is preparing to enter the Middle East and North Africa (MENA) region.”
- “Phase 3: Australasia (Future Expansion): The final stage of the current globalisation roadmap involves expanding into Australasia.”
- “Phase 4: With our own patented new products, we shall be entering into the lucrative UK, Europe and USA markets.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 4 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| KHIROYA, Parag | Director | 2011-02-02 | May 1963 | British |
| NATHWANI, Nilesh | Director | 2011-02-02 | Jul 1961 | British |
| NATHWANI, Panna | Director | 2016-03-31 | Jan 1964 | British |
Show 4 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CHAPMAN, Chris | Director | 2015-07-30 | 2019-09-12 |
| KHIROYA, Varsha | Director | 2016-03-31 | 2025-03-24 |
| KHIROYA, Varsha | Director | 2013-04-01 | 2016-03-30 |
| NATHWANI, Panna | Director | 2013-04-01 | 2016-03-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Parag Khiroya | Individual | Shares 25–50%, Voting 25–50% | 2025-03-24 | Active |
| Mr Nilesh Nathwani | Individual | Shares 25–50%, Voting 25–50% | 2025-03-24 | Active |
Filing timeline
Last 20 of 70 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-03-31 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-12-19 | AA | accounts | accounts with accounts type group |
| 2025-11-03 | CH01 | officers | change person director company with change date |
| 2025-11-03 | PSC04 | persons-with-significant-control | change to a person with significant control |
| 2025-10-27 | CH01 | officers | change person director company with change date |
| 2025-10-27 | PSC04 | persons-with-significant-control | change to a person with significant control |
| 2025-04-02 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-04-02 | PSC01 | persons-with-significant-control | notification of a person with significant control |
| 2025-04-02 | PSC01 | persons-with-significant-control | notification of a person with significant control |
| 2025-04-01 | TM01 | officers | termination director company with name termination date |
| 2025-04-01 | PSC09 | persons-with-significant-control | withdrawal of a person with significant control statement |
| 2025-03-26 | AA | accounts | accounts with accounts type group |
| 2025-02-26 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-02-22 | CS01 | confirmation-statement | confirmation statement with updates |
| 2023-12-19 | AA | accounts | accounts with accounts type group |
| 2023-09-12 | SH01 | capital | capital allotment shares |
| 2023-07-27 | RESOLUTIONS | resolution | resolution |
| 2023-07-27 | MA | incorporation | memorandum articles |
| 2023-03-09 | CS01 | confirmation-statement | confirmation statement with updates |
| 2022-12-19 | AA | accounts | accounts with accounts type group |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory